<code id='62C9D02D4F'></code><style id='62C9D02D4F'></style>
    • <acronym id='62C9D02D4F'></acronym>
      <center id='62C9D02D4F'><center id='62C9D02D4F'><tfoot id='62C9D02D4F'></tfoot></center><abbr id='62C9D02D4F'><dir id='62C9D02D4F'><tfoot id='62C9D02D4F'></tfoot><noframes id='62C9D02D4F'>

    • <optgroup id='62C9D02D4F'><strike id='62C9D02D4F'><sup id='62C9D02D4F'></sup></strike><code id='62C9D02D4F'></code></optgroup>
        1. <b id='62C9D02D4F'><label id='62C9D02D4F'><select id='62C9D02D4F'><dt id='62C9D02D4F'><span id='62C9D02D4F'></span></dt></select></label></b><u id='62C9D02D4F'></u>
          <i id='62C9D02D4F'><strike id='62C9D02D4F'><tt id='62C9D02D4F'><pre id='62C9D02D4F'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:272
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          FDA approves Sage Therapeutics’ rapid
          FDA approves Sage Therapeutics’ rapid

          AndrewHarnik/APTheFoodandDrugAdministrationonFridayapprovedanew,rapid-actingmedicinemadebySageTherap

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          ACIP vaccine advisory panel sees its vacancies filled

          AdobeTheDepartmentofHealthandHumanServicesannouncedThursdaythatitisfillingeightvacancies,includingth